|
|
|
|
Future allergy shots show promise
To prepare for the seasonal onslaught of pollen, most
allergy-stricken patients will try to find relief through
nonsedating antihistamines and nasal inhalers. Many others will
undergo allergen immunotherapy as a next step, receiving the
estimated 60 to 90 injections necessary for each treatment period.
Although allergy shots can be effective, treatment is often a
time-consuming and costly process. Preliminary results for new
therapies show promise and may soon offer allergy sufferers more
options with fewer injections.
|
| |
More>>
|
|
|
|
|
|
Evaluating a chronic cough: History often solves the mystery
A child's long-lasting cough is vexing for parents. One route to finding the cause is to, first, rule out serial viral illness and, then, piece together characteristics of the cough with findings from the history.
|
| |
More>>
|
|
|
|
|
|
Pertussis and its comeback—in persons of all ages
Despite widespread use of a childhood vaccine, pertussis remains a significant public health problem, with reported rates higher than they have been in decades. Its often mild manifestations in older persons make recognition challenging, but with new vaccines licensed for use in adolescents and adults, the time is right for heightened awareness.
|
| |
More>>
|
|
|
|
|
|
Allergic disease therapies key to patient quality of life
Quality of life (QOL) has become an issue in every branch of medicine, including ophthalmology. From an economic perspective, loss of productivity contributes to the economic burden of a disease in the same manner as the shared costs of treatment.
|
| |
More>>
|
|
|